Application of the linear-quadratic model to radioimmunotherapy: Further support for the advantage of longer-lived radionuclides

Keyphrases

• Radioimmunotherapy 100%
• Long-lived Radionuclides 100%
• Linear-quadratic Model 100%
• Tumor 75%
• Radionuclides 50%
• Total Dose 50%
• Dose Rate 50%
• Treatment Planning 25%
• Monoclonal Antibody 25%
• Time Dose 25%
• Dose Fractionation 25%
• Radiolabeled Antibody 25%
• Radiosensitivity 25%
• Repair Rate 25%
• Effective Dose 25%
• Fractionation Schedules 25%
• As(III) 25%
• Conventional Radiotherapy 25%
• Biologically Effective Dose 25%
• Relative Advantage 25%
• Therapeutic Gain 25%
• Bone Marrow Toxicity 25%

Medicine and Dentistry

• Radioisotope 100%
• Radioimmunotherapy 100%
• Linear Quadratic Models 100%
• Neoplasm 50%
• Treatment Planning 16%
• Low Drug Dose 16%
• Radiation Dose Fractionation 16%
• Monoclonal Antibody 16%
• Bone Marrow Toxicity 16%
• Radiosensitivity 16%
• Phosphorus 32 16%
• Radiation Therapy 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Radioisotope 100%
• Neoplasm 50%
• Monoclonal Antibody 16%
• Phosphorus 32 16%
• Dose Fractionation 16%
• Bone Marrow Toxicity 16%